| Year |
Citation |
Score |
| 2019 |
Mullen M, Quinn J, Greenwade M, Opara G, Beck-Noia H, Hagemann I, Hagemann A, Kuroki L, McCourt C, Thaker P, Powell M, Mutch D, Fuh K. AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis Gynecologic Oncology. 154: 79-80. DOI: 10.1016/J.Ygyno.2019.04.188 |
0.303 |
|
| 2017 |
Zhang X, Kim S, Hundal J, Herndon JM, Li S, Petti AA, Soysal SD, Li L, McLellan MD, Hoog J, Primeau T, Myers N, Vickery TL, Sturmoski M, Hagemann IS, et al. Breast cancer neoantigens can induce CD8 T cell responses and antitumor immunity. Cancer Immunology Research. PMID 28619968 DOI: 10.1158/2326-6066.Cir-16-0264 |
0.322 |
|
| 2016 |
Divine LM, Nguyen MR, Meller E, Desai RA, Arif B, Rankin EB, Bligard KH, Meyerson C, Hagemann IS, Massad M, Thaker PH, Hagemann AR, McCourt CK, Powell MA, Mutch DG, et al. AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer. Oncotarget. PMID 27764792 DOI: 10.18632/Oncotarget.12637 |
0.308 |
|
| 2015 |
Hagemann IS, O'Neill PK, Erill I, Pfeifer JD. Diagnostic yield of targeted next generation sequencing in various cancer types: An information-theoretic approach. Cancer Genetics. PMID 26227479 DOI: 10.1016/J.Cancergen.2015.05.030 |
0.334 |
|
| 2015 |
Chernock RD, Hagemann IS. Molecular pathology of hereditary and sporadic medullary thyroid carcinomas. American Journal of Clinical Pathology. 143: 768-77. PMID 25972318 DOI: 10.1309/Ajcphwacttuyj7Dd |
0.335 |
|
| 2015 |
Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, et al. Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer. 121: 631-9. PMID 25345567 DOI: 10.1002/Cncr.29089 |
0.304 |
|
| 2014 |
Sehn JK, Hagemann IS, Pfeifer JD, Cottrell CE, Lockwood CM. Diagnostic utility of targeted next-generation sequencing in problematic cases. The American Journal of Surgical Pathology. 38: 534-41. PMID 24451277 DOI: 10.1097/Pas.0000000000000161 |
0.316 |
|
| 2014 |
Hagemann IS, Govindan R, Javidan-Nejad C, Pfeifer JD, Cottrell CE. Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: e12-6. PMID 24419427 DOI: 10.1097/Jto.0B013E3182A7D22E |
0.331 |
|
| 2013 |
Hagemann IS, Al-Kateb H, Cottrell CE, Lockwood C, Nguyen T, Spencer D, Bredemeyer A, Head R, Varghese N, Nagarajan R, Seibert K, Duncavage EJ, Kulkarni S, Pfeifer JD. Abstract 813: Diagnostic yield of targeted next-generation sequencing for personalized cancer therapeutics. Cancer Research. 73: 813-813. DOI: 10.1158/1538-7445.Am2013-813 |
0.336 |
|
| 2013 |
Zsiros E, Lee H, Hagemann IS, Duttagupta P, Frank R, Garrabrant T, Levine BL, June CH, Tanyi J, Kandalaft L, Feldman M, Coukos G. Abstract 3968: Ovarian cancer chemokine microenvironment is conducive to homing of CD3/CD28 co-stimulated T cells prepared for adoptive transfer therapy. Cancer Research. 73: 3968-3968. DOI: 10.1158/1538-7445.Am2013-3968 |
0.344 |
|
| 2012 |
Lanitis E, Dangaj D, Hagemann IS, Song DG, Best A, Sandaltzopoulos R, Coukos G, Powell DJ. Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels. Plos One. 7: e49829. PMID 23189165 DOI: 10.1371/Journal.Pone.0049829 |
0.351 |
|
| 2012 |
Lanitis E, Poussin M, Hagemann IS, Coukos G, Sandaltzopoulos R, Scholler N, Powell DJ. Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 633-43. PMID 22127019 DOI: 10.1038/Mt.2011.256 |
0.328 |
|
| 2012 |
Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecologic Oncology. 124: 192-8. PMID 22040834 DOI: 10.1016/J.Ygyno.2011.09.039 |
0.311 |
|
| 2011 |
Hoyt CC, Hagemann IS, Hagemann AR, Wang L, Hung E, Lane K, Coukos G, Feldman MD. Performance characteristics and validation of automated tumor-infiltrating lymphocyte counting. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10562. PMID 28021887 DOI: 10.1200/Jco.2011.29.15_Suppl.10562 |
0.308 |
|
| 2011 |
Hagemann AR, Hagemann IS, Cadungog M, Hwang WT, Patel P, Lal P, Hammond R, Gimotty PA, Chu CS, Rubin SC, Birrer MJ, Powell DJ, Feldman MD, Coukos G. Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma. Cancer Biology & Therapy. 12: 367-77. PMID 21785280 DOI: 10.4161/Cbt.12.4.16908 |
0.313 |
|
| 2008 |
Hagemann IS, Miller DL, Klco JM, Nikiforovich GV, Baranski TJ. Structure of the complement factor 5a receptor-ligand complex studied by disulfide trapping and molecular modeling. The Journal of Biological Chemistry. 283: 7763-75. PMID 18195008 DOI: 10.1074/Jbc.M709467200 |
0.678 |
|
| 2007 |
Hagemann IS, Narzinski KD, Baranski TJ. E2F8 is a nonreceptor activator of heterotrimeric G proteins. Journal of Molecular Signaling. 2: 3. PMID 17394670 DOI: 10.1186/1750-2187-2-3 |
0.59 |
|
| 2006 |
Hagemann IS, Narzinski KD, Floyd DH, Baranski TJ. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking. The Journal of Biological Chemistry. 281: 36783-92. PMID 17023413 DOI: 10.1074/Jbc.M607686200 |
0.661 |
|
| 2006 |
Hagemann IS, Nikiforovich GV, Baranski TJ. Comparison of the retinitis pigmentosa mutations in rhodopsin with a functional map of the C5a receptor. Vision Research. 46: 4519-31. PMID 16962629 DOI: 10.1016/J.Visres.2006.07.010 |
0.621 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Lu C, Riedell P, Westervelt P, Miller C, Hagemann IS, Duncavage EJ, Mardis ER, Wilson RK, Ozenberger BA, Wartman LD. Abstract LB-109: Exome sequencing identifies common somatic mutations in an adult patient with a concurrent germ cell tumor (GCT) and acute myeloid leukemia (AML) suggesting a single clonal origin Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-109 |
0.297 |
|
| 2017 |
Uppaluri R, Zolkind P, Lin T, Nussenbaum B, Jackson RS, Rich J, Pipkorn P, Paniello R, Thorstad W, Michel L, Mudianto T, Oppelt PJ, Wildes TM, Dunn GP, Piccirillo JF, ... ... Hagemann IS, et al. Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 35: 6012-6012. DOI: 10.1200/Jco.2017.35.15_Suppl.6012 |
0.295 |
|
| 2011 |
Hagemann AR, Cadungog M, Hagemann IS, Hammond R, Adams SF, Chu CS, Rubin SC, Zhang L, Addya K, Birrer MJ, Gimotty PA, Coukos G. Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment. Cancer Biology & Therapy. 12: 357-66. PMID 21785264 DOI: 10.4161/Cbt.12.4.16951 |
0.294 |
|
| 2013 |
Hagemann IS, Cottrell CE, Lockwood CM. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy. Cancer Genetics. 206: 420-31. PMID 24388712 DOI: 10.1016/J.Cancergen.2013.11.003 |
0.291 |
|
| 2014 |
Cottrell CE, Al-Kateb H, Bredemeyer AJ, Duncavage EJ, Spencer DH, Abel HJ, Lockwood CM, Hagemann IS, O'Guin SM, Burcea LC, Sawyer CS, Oschwald DM, Stratman JL, Sher DA, Johnson MR, et al. Validation of a next-generation sequencing assay for clinical molecular oncology. The Journal of Molecular Diagnostics : Jmd. 16: 89-105. PMID 24211365 DOI: 10.1016/J.Jmoldx.2013.10.002 |
0.29 |
|
| 2020 |
Grither WR, Dickson BC, Fuh KC, Hagemann IS. Detection of a somatic gene fusion in a uterine tumor resembling ovarian sex cord tumor (UTROSCT). Gynecologic Oncology Reports. 34: 100636. PMID 32964092 DOI: 10.1016/J.Gore.2020.100636 |
0.287 |
|
| 2015 |
Skala SL, Hagemann IS. Optimal sampling of grossly normal omentum in staging of gynecologic malignancies. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 34: 281-7. PMID 25760907 DOI: 10.1097/Pgp.0000000000000148 |
0.286 |
|
| 2013 |
Hagemann IS, Pfeifer JD, Cao D. Mammaglobin expression in gynecologic adenocarcinomas. Human Pathology. 44: 628-35. PMID 23084633 DOI: 10.1016/J.Humpath.2012.07.013 |
0.286 |
|
| 2017 |
Mullen MM, Divine LM, Hagemann IS, Babb S, Powell MA. Endometrial adenosarcoma in the setting of a germline DICER1 mutation: A case report. Gynecologic Oncology Reports. 20: 121-124. PMID 28459098 DOI: 10.1016/J.Gore.2017.04.004 |
0.284 |
|
| 2014 |
Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F, Coukos G. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nature Medicine. 20: 607-15. PMID 24793239 DOI: 10.1038/Nm.3541 |
0.282 |
|
| 2015 |
Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, Hagemann IS, Levine BL, June CH, Zhang L, Wang E, Marincola FM, Bedognetti D, Powell DJ, Tanyi J, et al. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2840-50. PMID 25712684 DOI: 10.1158/1078-0432.Ccr-14-2777 |
0.278 |
|
| 2015 |
Sufficool KE, Lockwood CM, Abel HJ, Hagemann IS, Schumacher JA, Kelley TW, Duncavage EJ. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides. Journal of the American Academy of Dermatology. 73: 228-36.e2. PMID 26048061 DOI: 10.1016/J.Jaad.2015.04.030 |
0.276 |
|
| 2017 |
Ma CX, Suman V, Goetz MP, Northfelt DW, Burkard ME, Ademuyiwa F, Naughton MJ, Margenthaler J, Aft R, Gray RJ, Tevaarwerk AJ, Wilke LG, Haddad TC, Moynihan T, Loprenzi C, ... ... Hagemann IS, et al. A Phase II trial of neoadjuvant MK2206, an AKT inhibitor, with anastrozole in clinical stage 2 or 3 PIK3CA mutant ER positive and HER2 negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28874413 DOI: 10.1158/1078-0432.Ccr-17-1260 |
0.274 |
|
| 2013 |
Hussaini MO, Hagemann IS, Cox TM, Lockwood C, Seibert K, Kulkarni S, Pfeifer J, Duncavage EJ. Performance of next-generation sequencing for detection of clinically actionable genetic variants in cancer. Journal of Clinical Oncology. 31: 11099-11099. DOI: 10.1200/Jco.2013.31.15_Suppl.11099 |
0.271 |
|
| 2020 |
Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, ... ... Hagemann IS, et al. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32665297 DOI: 10.1158/1078-0432.Ccr-20-1695 |
0.27 |
|
| 2011 |
Hagemann IS, Hagemann AR, LiVolsi VA, Montone KT, Chu CS. Risk of occult malignancy in morcellated hysterectomy: a case series. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 30: 476-83. PMID 21804400 DOI: 10.1097/Pgp.0B013E3182107Ecf |
0.268 |
|
| 2017 |
Campbell KM, Lin T, Winkler AE, Zolkind P, Skidmore ZL, Barnell EK, Hagemann I, Mardis ER, Griffith M, Chernock RD, Griffith OL, Uppaluri R. Abstract 3847: Oral cavity squamous cell carcinoma xenografts display conservation of primary tumor genomic heterogeneity Cancer Research. 77: 3847-3847. DOI: 10.1158/1538-7445.Am2017-3847 |
0.266 |
|
| 2010 |
Monaco JP, Tomaszewski JE, Feldman MD, Hagemann I, Moradi M, Mousavi P, Boag A, Davidson C, Abolmaesumi P, Madabhushi A. High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models. Medical Image Analysis. 14: 617-29. PMID 20493759 DOI: 10.1016/J.Media.2010.04.007 |
0.265 |
|
| 2014 |
Zhang B, Xing X, Li J, Lowdon RF, Zhou Y, Lin N, Zhang B, Sundaram V, Chiappinelli KB, Hagemann IS, Mutch DG, Goodfellow PJ, Wang T. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. Bmc Genomics. 15: 868. PMID 25286960 DOI: 10.1186/1471-2164-15-868 |
0.265 |
|
| 2015 |
Raup VT, Johnson MH, Weese JR, Hagemann IS, Marshall SD, Brandes SB. Seminoma presenting as renal mass, inferior vena caval thrombus, and regressed testicular mass. Case Reports in Urology. 2015: 835962. PMID 25705542 DOI: 10.1155/2015/835962 |
0.264 |
|
| 2018 |
Nandy S, Hagemann IS, Powell MA, Siegel C, Zhu Q. Quantitative multispectral optical evaluation of human ovarian tissue using spatial frequency domain imaging. Biomedical Optics Express. 9: 2451-2456. PMID 29761000 DOI: 10.1364/Boe.9.002451 |
0.262 |
|
| 2016 |
Hagemann IS. Molecular Testing in Breast Cancer: A Guide to Current Practices. Archives of Pathology & Laboratory Medicine. 140: 815-24. PMID 27472240 DOI: 10.5858/Arpa.2016-0051-Ra |
0.26 |
|
| 2015 |
Stewart Massad L, Gao F, Hagemann I, Powell M. Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary. Gynecologic and Obstetric Investigation. PMID 26583769 DOI: 10.1159/000441791 |
0.259 |
|
| 2013 |
Zsiros E, Feldman M, Frank R, Hagemann I, Lee H, Tanyi J, Coukos G. Mapping the chemokine microenvironment in ovarian cancer Gynecologic Oncology. 130: e133. DOI: 10.1016/J.Ygyno.2013.04.379 |
0.258 |
|
| 2009 |
Hagemann IS, Lewis JS. A retrospective comparison of 2 methods of intraoperative margin evaluation during partial nephrectomy. The Journal of Urology. 181: 500-5. PMID 19084870 DOI: 10.1016/J.Juro.2008.10.020 |
0.246 |
|
| 2013 |
Zaino RJ, Abendroth C, Yemelyanova A, Oliva E, Lim D, Soslow R, Delair D, Hagemann IS, Montone K, Zhu J. Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible. Gynecologic Oncology. 128: 83-7. PMID 23063759 DOI: 10.1016/J.Ygyno.2012.09.035 |
0.24 |
|
| 2011 |
Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature. 475: 226-30. PMID 21753853 DOI: 10.1038/Nature10169 |
0.228 |
|
| 2023 |
Schab AM, Greenwade MM, Stock E, Lomonosova E, Cho K, Grither WR, Noia H, Wilke D, Mullen MM, Hagemann AR, Hagemann IS, Thaker PH, Kuroki LM, McCourt CK, Khabele D, et al. Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins. Molecular Cancer Research : McR. PMID 37527178 DOI: 10.1158/1541-7786.MCR-23-0347 |
0.223 |
|
| 2023 |
Kotnik EN, Mullen MM, Spies NC, Li T, Inkman M, Zhang J, Martins-Rodrigues F, Hagemann IS, McCourt CK, Thaker PH, Hagemann AR, Powell MA, Mutch DG, Khabele D, Longmore GD, et al. Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival. Communications Biology. 6: 688. PMID 37400526 DOI: 10.1038/s42003-023-05026-3 |
0.214 |
|
| 2016 |
Lu C, Riedell P, Miller CA, Hagemann IS, Westervelt P, Ozenberger BA, O'Laughlin M, Magrini V, Demeter RT, Duncavage EJ, Griffith M, Griffith OL, Wartman LD. A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia. Cold Spring Harbor Molecular Case Studies. 2: a000687. PMID 27148581 DOI: 10.1101/mcs.a000687 |
0.212 |
|
| 2017 |
Tandon B, Hagemann IS, Maluf HM, Pfeifer JD, Al-Kateb H. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 28177947 DOI: 10.1097/PGP.0000000000000365 |
0.204 |
|
| 2018 |
Owuor TO, Reid M, Reschke L, Hagemann I, Greco S, Modi Z, Moley KH. Maternal obesogenic diet induces endometrial hyperplasia, an early hallmark of endometrial cancer, in a diethylstilbestrol mouse model. Plos One. 13: e0186390. PMID 29775456 DOI: 10.1371/Journal.Pone.0186390 |
0.204 |
|
| 2017 |
Lee PJ, McNulty S, Duncavage EJ, Heusel JW, Hagemann IS. Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 29084048 DOI: 10.1097/Pgp.0000000000000459 |
0.199 |
|
| 2000 |
Hagemann IS, Khalifah PG, Ramirez AP, Cava RJ. Geometric magnetic frustration in olivines Physical Review B. 62: R771-R774. DOI: 10.1103/Physrevb.62.R771 |
0.198 |
|
| 2018 |
Nandy S, Mostafa A, Hagemann IS, Powell MA, Amidi E, Robinson K, Mutch DG, Siegel C, Zhu Q. Evaluation of Ovarian Cancer: Initial Application of Coregistered Photoacoustic Tomography and US. Radiology. 180666. PMID 30204078 DOI: 10.1148/Radiol.2018180666 |
0.195 |
|
| 2017 |
Palisoul ML, Quinn JM, Schepers E, Hagemann IS, Guo L, Reger K, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC. Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer. Molecular Cancer Therapeutics. PMID 28904132 DOI: 10.1158/1535-7163.MCT-17-0587 |
0.194 |
|
| 2001 |
Hagemann IS, Huang Q, Gao XP, Ramirez AP, Cava RJ. Geometric magnetic frustration in Ba(2)Sn(2)Ga(3)ZnCr(7)O(22): a two-dimensional spinel based Kagomé lattice. Physical Review Letters. 86: 894-7. PMID 11177967 DOI: 10.1103/Physrevlett.86.894 |
0.193 |
|
| 2020 |
Yang C, Zhang L, Love-Gregory L, Sun L, Hagemann IS, Cao D. Identification of Novel ALK Rearrangements in Gynecologic Clear Cell Carcinoma. International Journal of Cancer. PMID 33034056 DOI: 10.1002/ijc.33330 |
0.193 |
|
| 2022 |
Sun L, Schroeder MC, Hagemann IS, Pfeifer JD, Schwarz JK, Grigsby PW, Markovina S, Lin AJ. Expression of Potential Biomarker Targets by Immunohistochemistry in Cervical Carcinomas. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 35067601 DOI: 10.1097/PGP.0000000000000853 |
0.193 |
|
| 2021 |
Mullen MM, Lomonosova E, Toboni MD, Oplt A, Cybulla E, Blachut B, Zhao P, Noia H, Wilke D, Rankin EB, Kuroki LM, Hagemann AR, Hagemann IS, McCourt CK, Thaker PH, et al. GAS6/AXL inhibition enhances ovarian cancer sensitivity to chemotherapy and PARP inhibition through increased DNA damage and enhanced replication stress. Molecular Cancer Research : McR. PMID 34670865 DOI: 10.1158/1541-7786.MCR-21-0302 |
0.193 |
|
| 2019 |
Westbrook TC, Hagemann IS, Ley J, Chen K, Palka K, Liu J, Chen L, Oppelt P, Adkins D. Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer. Medical Oncology (Northwood, London, England). 37: 12. PMID 31865465 DOI: 10.1007/s12032-019-1336-3 |
0.192 |
|
| 2006 |
Foo ML, Huang Q, Lynn JW, Lee WL, Klimczuk T, Hagemann IS, Ong NP, Cava RJ. Synthesis, structure and physical properties of Ru ferrites: BaMRu 5O11 (M=Li and Cu) and BaM′2Ru 4O11 (M′=Mn, Fe and Co) Journal of Solid State Chemistry. 179: 563-572. DOI: 10.1016/J.Jssc.2005.11.014 |
0.192 |
|
| 2017 |
Lee PJ, Yoo NS, Hagemann IS, Pfeifer JD, Cottrell CE, Abel HJ, Duncavage EJ. Spectrum of Mutations in Leiomyosarcomas Identified By Clinical Targeted Next-Generation Sequencing. Experimental and Molecular Pathology. PMID 28093192 DOI: 10.1016/J.Yexmp.2017.01.012 |
0.191 |
|
| 2021 |
Sun L, Wu A, Bean GR, Hagemann IS, Lin CY. Molecular Testing in Breast Cancer: Current Status and Future Directions. The Journal of Molecular Diagnostics : Jmd. PMID 34454106 DOI: 10.1016/j.jmoldx.2021.07.026 |
0.19 |
|
| 2023 |
Sawant M, Wilson A, Sridaran D, Mahajan K, O'Conor CJ, Hagemann IS, Luo J, Weimholt C, Li T, Roa JC, Pandey A, Wu X, Mahajan NP. Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. Oncogene. PMID 37330596 DOI: 10.1038/s41388-023-02747-x |
0.188 |
|
| 2018 |
Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC. Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer. Molecular Cancer Therapeutics. PMID 30478151 DOI: 10.1158/1535-7163.MCT-18-0537 |
0.186 |
|
| 2023 |
Cheng X, Sun Y, Highkin M, Vemalapally N, Jin X, Zhou B, Prior JL, Tipton AR, Li S, Iliuk A, Achilefu S, Hagemann IS, Edwards JR, Bose R. Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 -Cyclin D1 axis driving tumorigenesis and drug resistance. Cancer Research. PMID 37272756 DOI: 10.1158/0008-5472.CAN-22-3558 |
0.178 |
|
| 2023 |
Ademuyiwa FO, Northfelt DW, O'Connor T, Levine E, Luo J, Tao Y, Hoog J, Laury ML, Summa T, Hammerschmidt T, Guo Z, Frith A, Weilbaecher K, Opyrchal M, Aft R, ... ... Hagemann IS, et al. A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN). Npj Breast Cancer. 9: 1. PMID 36609389 DOI: 10.1038/s41523-022-00504-z |
0.16 |
|
| 2021 |
Hagemann IS, Deng W, Zaino RJ, Powell MA, Gunderson C, Cosgrove C, Mathews C, Pearl ML, Waggoner S, Ghebre R, Lele S, Guntupalli S, Secord AA, Ioffe O, Park K, et al. The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. Gynecologic Oncology. PMID 33423806 DOI: 10.1016/j.ygyno.2020.12.040 |
0.157 |
|
| 2022 |
Hagemann IS, Bridge JA, Tafe LJ, Hameed MR, Moncur JT, Bellizzi AM, Dolan M, Vasalos P, Kane ME, Souers RJ, Yemelyanova A. Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. Archives of Pathology & Laboratory Medicine. PMID 36538387 DOI: 10.5858/arpa.2022-0229-CP |
0.154 |
|
| 2023 |
Hagemann IS, Deng W, Zaino RJ, Powell MA, Gunderson Jackson C, Cosgrove C, Mathews C, Pearl ML, Waggoner S, Ghebre R, Lele S, Guntupalli S, Secord AA, Ioffe O, Rasty G, et al. Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women. Gynecologic Oncology. 177: 38-45. PMID 37634258 DOI: 10.1016/j.ygyno.2023.08.005 |
0.15 |
|
| 2021 |
Ademuyiwa FO, Chen I, Luo J, Rimawi MF, Hagemann IS, Fisk B, Jeffers G, Skidmore ZL, Basu A, Richters M, Ma CX, Weilbaecher K, Davis J, Suresh R, Peterson LL, et al. Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer. Breast Cancer Research and Treatment. PMID 34173924 DOI: 10.1007/s10549-021-06307-3 |
0.145 |
|
| 2023 |
Grither WR, Hagemann IS, Powell MA, Mullen MM. Attack of the clones: Unveiling subclonal/heterogenous mismatch repair (MMR)/microsatellite instability (MSI) status in endometrial cancer (EC). Cancer. PMID 37902951 DOI: 10.1002/cncr.35067 |
0.138 |
|
| 2022 |
Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, Vashist TD, Tran Huynh AM, Dou Y, Gou X, Huang C, Shi Z, Wen B, Korchina V, Gibbs RA, ... ... Hagemann IS, et al. Proteogenomic markers of chemotherapy resistance and response in triple negative breast cancer. Cancer Discovery. PMID 36001024 DOI: 10.1158/2159-8290.CD-22-0200 |
0.137 |
|
| 2023 |
Chapagain U, Krigman HR, Hagemann IS, Weiss MC, Sun L. fusion-associated uterine sarcoma and response to Imatinib: A case report. Gynecologic Oncology Reports. 49: 101270. PMID 37711974 DOI: 10.1016/j.gore.2023.101270 |
0.137 |
|
| 2021 |
Hassan MM, Cyr AE, Hagemann IS. Estimating the Breast Cancer Risk Conferred by Germline Mutations. Clinical Chemistry. PMID 34922362 DOI: 10.1093/clinchem/hvab252 |
0.134 |
|
| 2019 |
Rao B, Leng X, Zeng Y, Lin Y, Chen R, Zhou Q, Hagemann AR, Kuroki LM, McCourt CK, Mutch DG, Powell MA, Hagemann IS, Zhu Q. Optical Resolution Photoacoustic Microscopy of Ovary and Fallopian Tube. Scientific Reports. 9: 14306. PMID 31586106 DOI: 10.1038/S41598-019-50743-7 |
0.133 |
|
| 2024 |
Lee JS, Chang J, Hagemann IS, Bennett DL. Malignant Phyllodes Tumor: Imaging Features With Histopathologic Correlation. Journal of Breast Imaging. 3: 703-711. PMID 38424928 DOI: 10.1093/jbi/wbab065 |
0.122 |
|
| 2022 |
Ademuyiwa FO, Gao F, Street CR, Chen I, Northfelt DW, Wesolowski R, Arora M, Brufsky A, Dees EC, Santa-Maria CA, Connolly RM, Force J, Moreno-Aspitia A, Herndon JM, Carmody M, ... ... Hagemann IS, et al. A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. Npj Breast Cancer. 8: 134. PMID 36585404 DOI: 10.1038/s41523-022-00500-3 |
0.117 |
|
| 2008 |
Hagemann IS, Lu J, Lewis JS. Basaloid squamous cell carcinoma arising of the renal pelvis International Journal of Surgical Pathology. 16: 199-201. PMID 18417681 DOI: 10.1177/1066896907306197 |
0.115 |
|
| 2021 |
Uppaluri R, Campbell KM, Egloff AM, Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson R, Pipkorn P, Michel LS, Ley J, Oppelt P, Dunn GP, Barnell EK, ... ... Hagemann IS, et al. Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 27: 357. PMID 33397681 DOI: 10.1158/1078-0432.CCR-20-4484 |
0.112 |
|
| 2024 |
Kahaki S, Hagemann IS, Cha KH, Trindade C, Petrick N, Kostelecky N, Borden LE, Atwi D, Fung KM, Chen W. End-to-end deep learning method for predicting hormonal treatment response in women with atypical endometrial hyperplasia or endometrial cancer. Journal of Medical Imaging (Bellingham, Wash.). 11: 017502. PMID 38370423 DOI: 10.1117/1.JMI.11.1.017502 |
0.109 |
|
| 2017 |
Toriola AT, Dang HX, Hagemann IS, Appleton CM, Colditz GA, Luo J, Maher CA. Increased breast tissue receptor activator of nuclear factor-κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women. Oncotarget. 8: 73787-73792. PMID 29088745 DOI: 10.18632/oncotarget.17909 |
0.109 |
|
| 2017 |
Toriola AT, Dang HX, Hagemann IS, Appleton CM, Colditz GA, Luo J, Maher CA. Increased breast tissue receptor activator of nuclear factor- κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women. Oncotarget. PMID 28575868 DOI: 10.18632/oncotarget.17909 |
0.109 |
|
| 2021 |
Zhu Q, Ademuyiwa FO, Young C, Appleton C, Covington MF, Ma C, Sanati S, Hagemann IS, Mostafa A, Uddin KMS, Grigsby I, Frith AE, Hernandez-Aya LF, Poplack SS. Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography. Breast Cancer Research and Treatment. PMID 33970392 DOI: 10.1007/s10549-021-06239-y |
0.109 |
|
| 2019 |
Zeng Y, Nandy S, Rao B, Li S, Hagemann AR, Kuroki LK, McCourt C, Mutch DG, Powell MA, Hagemann IS, Zhu Q. Histogram Analysis of en face Scattering Coefficient Map Predicts Malignancy in Human Ovarian Tissue. Journal of Biophotonics. e201900115. PMID 31304678 DOI: 10.1002/Jbio.201900115 |
0.108 |
|
| 2023 |
Li S, Luo H, Kou S, Hagemann IS, Zhu Q. Depth-resolved attenuation mapping of the human ovary and fallopian tube using optical coherence tomography. Journal of Biophotonics. e202300002. PMID 36916760 DOI: 10.1002/jbio.202300002 |
0.105 |
|
| 2022 |
Leng X, Kou S, Lin Y, Hagemann AR, Hagemann IS, Thaker PH, Kuroki LM, McCourt CK, Mutch DG, Siegel C, Powell MA, Zhu Q. Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy. Scientific Reports. 12: 15850. PMID 36151126 DOI: 10.1038/s41598-022-19778-1 |
0.105 |
|
| 2017 |
Li J, Xing X, Li D, Zhang B, Mutch DG, Hagemann IS, Wang T. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma. Neoplasia (New York, N.Y.). 19: 100-111. PMID 28088687 DOI: 10.1016/J.Neo.2016.12.009 |
0.099 |
|
| 2014 |
Zutter MM, Bloom KJ, Cheng L, Hagemann IS, Kaufman JH, Krasinskas AM, Lazar AJ, Leonard DG, Lindeman NI, Moyer AM, Nikiforova MN, Nowak JA, Pfeifer JD, Sepulveda AR, Willis JE, et al. The Cancer Genomics Resource List 2014. Archives of Pathology & Laboratory Medicine. PMID 25436904 DOI: 10.5858/Arpa.2014-0330-Cp |
0.094 |
|
| 2023 |
Kahaki S, Hagemann IS, Cha K, Trindade CJ, Petrick N, Kostelecky N, Chen W. Weakly Supervised Deep Learning for Predicting the Response to Hormonal Treatment of Women with Atypical Endometrial Hyperplasia: A Feasibility Study. Proceedings of Spie--the International Society For Optical Engineering. 12471. PMID 37159719 DOI: 10.1117/12.2652912 |
0.093 |
|
| 2021 |
Gavrielides MA, Ronnett BM, Vang R, Barak S, Lee E, Staats PN, Jenson E, Skaria P, Sheikhzadeh F, Miller M, Hagemann IS, Petrick N, Seidman JD. Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging: A Multisite Observer Study. Archives of Pathology & Laboratory Medicine. PMID 33635941 DOI: 10.5858/arpa.2020-0579-OA |
0.089 |
|
| 2017 |
Hill K, Diaz J, Hagemann IS, Chernock RD. Multiple Myeloma Presenting as Massive Amyloid Deposition in a Parathyroid Gland Associated with Amyloid Goiter: A Medullary Thyroid Carcinoma Mimic on Intra-operative Frozen Section. Head and Neck Pathology. PMID 28879586 DOI: 10.1007/s12105-017-0853-7 |
0.084 |
|
| 2018 |
Dandulakis MG, Mattis AJ, Hagemann AR, Hagemann IS. Cervical clear cell adenocarcinoma with an exceptionally low proliferation index: Report of a case. Gynecologic Oncology Reports. 23: 16-19. PMID 29326971 DOI: 10.1016/j.gore.2017.12.006 |
0.078 |
|
| 2021 |
Arudra SKC, Garvey LC, Hagemann IS. In-laboratory breast specimen radiography reduces tissue block utilization and improves turnaround time of pathologic examination. Bmc Medical Imaging. 21: 59. PMID 33757455 DOI: 10.1186/s12880-021-00589-1 |
0.077 |
|
| 2008 |
Hagemann IS, Lu J, Lewis JS. Basaloid squamous cell carcinoma arising in the renal pelvis (International Journal of Surgical Pathology (2008) 16, (199-201) DOI: 10.1177/ 1066896907306197) International Journal of Surgical Pathology. 16: 355. DOI: 10.1177/1066896908321993 |
0.075 |
|
| 2017 |
Huynh TV, Cipriano CA, Hagemann IS, Friedman MV. Osteolipoma of the knee. Radiology Case Reports. 12: 124-129. PMID 28228894 DOI: 10.1016/j.radcr.2016.10.015 |
0.07 |
|
| 2014 |
Hagemann IS. Overview of Technical Aspects and Chemistries of Next-Generation Sequencing Clinical Genomics. 3-19. DOI: 10.1016/B978-0-12-404748-8.00001-0 |
0.07 |
|
| 2020 |
He M, Skaria P, Kreutz K, Chen L, Hagemann IS, Carter EB, Mysorekar IU, Nelson DM, Pfeifer J, Dehner LP. Histopathology of Third Trimester Placenta from SARS-CoV-2-Positive Women. Fetal and Pediatric Pathology. 1-10. PMID 33040615 DOI: 10.1080/15513815.2020.1828517 |
0.069 |
|
| 2018 |
Sun L, Zhang L, Krigman HR, Hagemann IS. p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions. Journal of Lower Genital Tract Disease. 22: 104-109. PMID 29570565 DOI: 10.1097/LGT.0000000000000370 |
0.067 |
|
| 2012 |
Hagemann IS, Pasha TL, Roberts SA, Yum SW, Zhang PJ. Aberrant connexin 43 and 26 expression in cervical dysplasia. Analytical and Quantitative Cytology and Histology / the International Academy of Cytology [and] American Society of Cytology. 34: 28-40. PMID 22590817 |
0.066 |
|
| 2019 |
Gavrielides MA, Miller M, Hagemann IS, Abdelal H, Alipour Z, Chen JF, Salari B, Sun L, Zhou H, Seidman JD. Clinical Decision Support for Ovarian Carcinoma Subtype Classification: A Pilot Observer Study With Pathology Trainees. Archives of Pathology & Laboratory Medicine. PMID 31816269 DOI: 10.5858/arpa.2019-0390-OA |
0.066 |
|
| 2020 |
Hagemann IS. Sequence Now, Later, or Never? Clinical Chemistry. 66: 883-885. PMID 32628757 DOI: 10.1093/clinchem/hvaa053 |
0.062 |
|
| 2021 |
Hagemann IS, Elliott R, Kalof A, Keung ES, Patil N, Peterson JEG. Advancing Fellowship Training in Selective Pathology: Design and Implementation of the Milestones 2.0. Archives of Pathology & Laboratory Medicine. PMID 34324625 DOI: 10.5858/arpa.2021-0112-OA |
0.062 |
|
| 2023 |
Luo H, Li S, Kou S, Lin Y, Hagemann IS, Zhu Q. Enhanced 3D visualization of human fallopian tube morphology using a miniature optical coherence tomography catheter. Biomedical Optics Express. 14: 3225-3233. PMID 37497483 DOI: 10.1364/BOE.489708 |
0.061 |
|
| 2008 |
Finger S, Hagemann IS. Benjamin Franklin's risk factors for gout and stones: from genes and diet to possible lead poisoning. Proceedings of the American Philosophical Society. 152: 189-206. PMID 19244863 |
0.06 |
|
| 2021 |
Poplack SP, Young CA, Hagemann IS, Luo J, Herman CR, Wiele K, Li S, Zeng Y, Covington MF, Zhu Q. Prospective assessment of adjunctive ultrasound-guided diffuse optical tomography in women undergoing breast biopsy: Impact on BI-RADS assessments. European Journal of Radiology. 145: 110029. PMID 34801874 DOI: 10.1016/j.ejrad.2021.110029 |
0.057 |
|
| 2011 |
Tsai DE, Hagemann IS, Morrissette JJ, Daber R, Xu D, Schuster SJ, Bloom RD, Ahya VN, Jessup M, Makar GA, Chen S, Reshef R. Allograft versus non-allograft post-transplant lymphoproliferative disorder, characterization of two distinct subtypes as defined by presentation, histology, and outcome: A case series of 165 patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8054. PMID 28023539 DOI: 10.1200/Jco.2011.29.15_Suppl.8054 |
0.057 |
|
| 2020 |
Rubin A, Chen JF, Veade A, Hagemann IS. Pathologic Findings in Fallopian Tubes of Women with Chronic Pelvic Pain after Essure Placement. Contraception. PMID 32353358 DOI: 10.1016/j.contraception.2020.04.010 |
0.055 |
|
| 2024 |
Desouki MM, Hagemann IS, Khoury T, Fadare O, Bhargava R, Clark JL, Deavers MT, Jorns JM, Khan A, Cosar EF, Karabakhtsian RG, Klein ME, Pinto A, Ali M. Selective breast/gynecologic pathology fellowship training in the United States: Experience of program directors. Academic Pathology. 11: 100103. PMID 38380270 DOI: 10.1016/j.acpath.2023.100103 |
0.053 |
|
| 2021 |
Dehner CA, Hagemann IS, Chrisinger JSA. Retroperitoneal Dedifferentiated Liposarcoma. American Journal of Clinical Pathology. PMID 34125170 DOI: 10.1093/ajcp/aqab051 |
0.048 |
|
| 2023 |
Hagemann IS, Zehir A, Suarez CJ, Furtado LV, Halley J, Kane M, Mot N, Vasalos P, Moncur JT, Konnick EQ. In silico approaches to proficiency testing: Considerations for continued feasibility. The Journal of Molecular Diagnostics : Jmd. PMID 37088136 DOI: 10.1016/j.jmoldx.2023.04.002 |
0.031 |
|
| 2006 |
Foo ML, Huang Q, Lynn JW, Lee W, Klimczuk T, Hagemann IS, Ong NP, Cava RJ. Synthesis, Structure and Physical Properties of Ru Ferrites: BaMRu5O11 (M: Li and Cu) and BaM′2Ru4O11 (M′: Mn, Fe, and Co). Cheminform. 37. DOI: 10.1002/chin.200617014 |
0.028 |
|
| 2000 |
Hagemann IS, Khalifah PG, Ramirez AP, Cava RJ. Geometric magnetic frustration in olivines Physical Review B - Condensed Matter and Materials Physics. 62: R771-R774. |
0.022 |
|
| 1996 |
Hagemann I. PV in buildings - the influence of pv on the design and planning process of a building Renewable Energy. 8: 467-470. DOI: 10.1016/0960-1481(96)88900-2 |
0.012 |
|
| 2007 |
Hagemann IS. A careful look at community CPR training. Missouri Medicine. 104: 481-4. PMID 18210908 |
0.01 |
|
| Hide low-probability matches. |